0001144204-13-004103.txt : 20130125
0001144204-13-004103.hdr.sgml : 20130125
20130125181123
ACCESSION NUMBER: 0001144204-13-004103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130123
FILED AS OF DATE: 20130125
DATE AS OF CHANGE: 20130125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Conover Charles
CENTRAL INDEX KEY: 0001538563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12957
FILM NUMBER: 13549817
MAIL ADDRESS:
STREET 1: 20 KINGSBRIDGE ROAD
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000727510
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222372868
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 KINGSBRIDGE ROAD
STREET 2: ATT: GENERAL COUNSEL
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
BUSINESS PHONE: 732-980-4500
MAIL ADDRESS:
STREET 1: 20 KINGSBRIDGE ROAD
STREET 2: ATT: GENERAL COUNSEL
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20021211
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20021210
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON INC
DATE OF NAME CHANGE: 19920703
4
1
v333066_4.xml
OWNERSHIP DOCUMENT
X0306
4
2013-01-23
0
0000727510
ENZON PHARMACEUTICALS INC
ENZN
0001538563
Conover Charles
C/O ENZON PHARMACEUTICALS, INC.
20 KINGSBRIDGE ROAD
PISCATAWAY
NJ
08854
0
1
0
0
SVP, R&D Program Management
Common Stock
2013-01-23
4
A
0
2343
0
A
74793
D
This Form 4 is being filed to report the accelerated vesting of 2,343 restricted stock units (RSUs) that were originally granted to the Reporting Person on August 12, 2011. The August 12, 2011 grant consisted of 7,028 RSUs, which vest in full on August 12, 2014 if the Reporting Person remains employed by the Issuer on such date, provided that 50% of the RSUs are subject to accelerated vesting upon the achievement of certain performance milestones. Certain of the performance milestones applicable to the RSU grant were achieved, resulting in the accelerated vesting of 2,343 of the RSUs on January 23, 2013.
Because the RSUs granted to the Reporting Person on August 12, 2011 were previously included in the number of shares of common stock reported as beneficially owned by the Reporting Person, the accelerated vesting of 2,343 of the RSUs did not affect the number of shares reported as beneficially owned.
All RSU amounts in this Form 4 reflect an equitable adjustment approved by the Compensation Committee and made to the Issuer's outstanding RSUs in connection with the special cash dividend of $2.00 per share paid by the Issuer on December 21, 2012 to stockholders of record as of December 10, 2012.
/s/ Andrew Rackear, Attorney-in-Fact
2013-01-25